CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of <i>Nras</i> <sup>G12D</sup>-driven chronic myelomonocytic leukemia.

Cancer Biol Ther · 2026 · PMC13290085 · PMID 42330053

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not as significantno p-value reported

Although T cells from PB and SP demonstrated increased CD69 expression, this increase was not as significant as that in the BM ( Figure 1C ).

also in 271 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of &lt;i&gt;Nras&lt;/i&gt; &lt;sup&gt;G12D&lt;/sup&gt;-driven chronic myelomonocytic leukemia.

The sentences

CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of <i>Nras</i> <sup>G12D</sup>-driven chronic myelomonocytic leukemia.